RenovoRx (RNXT) Current Assets (2020 - 2026)
RenovoRx (RNXT) posted Current Assets of $13.7 million for Q1 2026, up 73.82% sequentially from $7.9 million in Q4 2025, and down 12.86% YoY from $15.7 million in Q1 2025.
RenovoRx (RNXT) Current Assets (2020 - 2026) Analysis & Trends
RenovoRx has reported Current Assets for 7 years, with the latest figure at $13.7 million in Q1 2026.
- Quarterly Current Assets fell 12.86% year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.7 million (down 12.86% YoY) and the FY2025 annual result came in at $7.9 million, up 0.83% from the prior year.
- Current Assets grew to $13.7 million in Q1 2026 per RNXT's latest filing, from $7.9 million in the prior quarter.
- Over five years, Current Assets peaked at $15.7 million in Q1 2025 and troughed at $1.5 million in Q4 2023.
- A 5-year average of $10.2 million and a median of $11.0 million in 2025 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2024: Current Assets sank 79.82% in 2023, then soared 433.97% in 2024.
- Over 5 years, Current Assets stood at $7.3 million in 2022, then tumbled by 79.82% to $1.5 million in 2023, then jumped by 433.97% to $7.8 million in 2024, then gained by 0.83% to $7.9 million in 2025, then soared by 73.82% to $13.7 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $13.7 million, $7.9 million, and $11.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 1.76 Bn |
| 10 | RenovoRx | 61.96 Mn | 61.96 Mn | 766,000.00 | 10.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.81 Mn |
| Mar 31, 2026 | 13.72 Mn |
| Dec 31, 2025 | 7.89 Mn |
| Sep 30, 2025 | 10.98 Mn |
| Jun 30, 2025 | 13.40 Mn |
| Mar 31, 2025 | 15.75 Mn |
| Dec 31, 2024 | 7.83 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 7.27 Mn |
| Sep 30, 2022 | 9.25 Mn |
| Jun 30, 2022 | 11.24 Mn |
| Mar 31, 2022 | 13.94 Mn |
| Dec 31, 2021 | 16.28 Mn |
| Sep 30, 2021 | 18.16 Mn |
| Dec 31, 2020 | 1.91 Mn |